New diagnostic platform enables automated HER2 scoring of breast cancer tissue samples
Știință și Tehnologie
BMEF (BME Frontiers) Jun 25 2026 Reviewed Researchers at the University of California, Los Angeles have developed a compact, cost-effective diagnostic platform combining lensfree holography and deep learning for automated HER2 scoring of breast cancer tissue samples. Their findings have been officially published in BME Frontiers (BMEF) , presenting a transformative alternative to expensive and bulky conventional digital pathology equipment for clinical use. Accurate HER2 evaluation is a
din zilele anterioare